CHF Solutions, Inc. Release: Seven Studies on Ultrafiltration Presented at Heart Failure Society of America Annual Meeting

BROOKLYN PARK, Minn.--(BUSINESS WIRE)--CHF Solutions announced today that seven studies supporting ultrafiltration therapy’s effectiveness and benefits in treating fluid overload in heart failure patients were presented at the recent Heart Failure Society of America (HFSA) 2008 Annual Scientific Meeting in Toronto, Canada. The company’s Aquapheresis™ therapy is a simplified method for safely and effectively removing the excess salt and water in patients with fluid overload.